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Abstract 
Background: 
Transient ischaemic attack (TIA) incurs a risk of recurrent stroke that can be dramatically 
reduced by urgent guideline-recommended management at the point of first medical contact. 
Aims: 
This study describes the prevalence and associations of new TIA presentations to general 
practice (GP) registrars and the management undertaken. 
Methods: 
A cross-sectional analysis of the Registrar Clinical Encounters in Training (ReCEnT) cohort 
study. GP-registrars from five Australian states (urban to very remote practices) collected data 
on 60 consecutive patient encounters during each of three six-month training terms. The 
proportion of problems managed being new TIAs and proportion of TIAs with guideline-
recommended management were calculated. Univariate and multivariable logistic regression 
established associations of patient, registrar and practice factors with a problem being a new 
TIA. 
Results: 
1,331 GP-registrars contributed data (response rate 95.8%). Of 250,625 problems, there were 65 
new TIAs diagnosed (0.03% [95%CI: 0.02%-0.03%]).  GP-registrars were more likely to seek 
help, generate learning goals and spend more time for a new TIA compared to other problems. 
Compliance with management guidelines was modest: 15.4% ordered brain and arterial 
imaging, 36.9% prescribed antiplatelet medication and 3.1% prescribed antihypertensive 
medication.  
Conclusions: 
TIA is a very infrequent presentation for GP-registrars, giving little clinical opportunity to 
reinforce training program education regarding guideline-recommended management. GP-
registrars found TIAs challenging and management was not ideal. Since most TIAs first present 
to general practice and urgent management is essential, an enhanced model of care utilising 
rapid access to specialist TIA support and follow-up could improve guideline compliance.
 Main Text 
 
Introduction 
Transient ischaemic attack (TIA) is an urgent and important problem because the risk of 
recurrent stroke is up to 15% within 90 days,(1) with the greatest proportion of this risk 
occurring in the first 48 hours.(2) In Australia, stroke imposes a significant burden, causing 
6% of all deaths in 2009,(3) and in 2012 more than 420,000 people were living with disability 
from stroke.(4) Proven management strategies for TIA can reduce relative risk of subsequent 
stroke by 80%, but they rely upon rapid assessment of TIA and prompt commencement of 
secondary prevention.(5) Evidence-based practice guidelines internationally have 
incorporated these management strategies.(6, 7) For Australian practice, they are detailed in 
the National Stroke Foundation guidelines (hereafter, guidelines).(8)  
The majority of patients with TIA first present to general practice(9) but there is limited 
evidence describing general practitioner (GP) management of TIA. In Australia this evidence 
suggests that compliance with guidelines may not be ideal.(10, 11) This poses the question of 
how early career GPs and GP trainees (known in Australia as GP-registrars) are prepared for 
managing this condition. GP-registrars essentially practice as independent practitioners 
(including for test-ordering, prescribing, specialist referral, and billing), although they have 
recourse to advice and support from experienced GP supervisors within a regionalised 
national GP training program(12). 
Previous research shows that when compared to established GPs, GP-registrars see 
substantially less chronic disease,(13) and older patients prefer to see their usual GP.(14) 
Increasing age is a major risk factor for TIA(7) and, unfortunately, patients often do not 
perceive TIA symptoms to be urgent.(15) It is unknown how these potential influences 
interact in determining the prevalence of TIA presentations in GP-registrars’ clinical 
experience. 
 GP training relies upon clinical exposure to disease conditions to reinforce good management 
practices. Consequently, it is important to know how often GP-registrars see TIA and how 
they manage it.   
 
Aims 
To describe the prevalence of clinically diagnosed new TIA presentations, the associations of 
practice, registrar and patient factors with new TIA presentations, and the management 
actions undertaken by GP-registrars.  
 
Methods 
Participants 
This was a cross-sectional analysis of data from the Registrar Clinical Encounters in Training 
(ReCEnT) cohort study. Data was from 14 rounds of data collection, 2010-16. The study 
methodology has been described in detail elsewhere.(16) Briefly, ReCEnT is an ongoing 
cohort study of GP-registrars’ in-practice clinical experiences undertaken (2010-2015) in five 
of Australia’s then seventeen regional training organisations (RTOs) and (2016) in three of 
Australia’s current nine RTOs. These encompass urban, rural, remote and very remote 
practices  
Procedures 
Participating GP-registrar characteristics and the characteristics of their training practice are 
documented. Registrars record the details of sixty consecutive patient consultations, 
representing approximately one week of consultations, once in each of three six-month 
training terms. In one RTO, registrars in a fourth elective term also participated. Data 
collection is conducted around the mid-point of the term.   
 Outcome factors 
The primary outcome factor was whether a new TIA problem was encountered for patients 
aged 18 or over. TIA was defined as an initial clinical diagnosis made by the GP-registrar at 
first consultation following assessment of a patient presenting with a transient neurological 
disturbance. Problems addressed in the consultation were coded according to the International 
Classification of Primary Care, second edition (ICPC-2).(17) New TIA problems were 
defined by ICPC-2 code K89 001 (transient ischaemic attack), K89 014 (amaurosis fugax), 
K89 015 (reversible ischaemic neurological deficit) and the problem having been recorded as 
‘new’ by the GP-registrar.  
 
Independent variables  
Other variables related to the patient, registrar, practice and consultation.  
Patient factors were age and gender.  
Registrar factors were gender, training term, and place of medical qualification (Australia or 
international). 
Practice factors included practice size (full time equivalent number of GPs), routinely bulk-
bills (that is, there is no financial cost to the patient for the consultation), rurality, and socio-
economic status of the practice location. Practice postcode was used to define the Australian 
Standard Geographical Classification-Remoteness Area (ASGC-RA) classification(18) (the 
degree of rurality) and the Socioeconomic Index for Areas (SEIFA) Index of 
Disadvantage(19) of the practice location reported as a decile. The lower the SEIFA score the 
more disadvantaged the area. 
Consultation factors were duration of consultation, whether the registrar sought clinical 
information or assistance during the consultation (from their GP supervisor, a specialist, other 
 health professional, or from electronic or hard-copy resources), and whether they generated 
any ‘learning goals’ (clinical questions to be pursued after the consultation had finished).  
Medications prescribed were classified using the Anatomic Therapeutic Chemical (ATC) 
Classification codes(20): antiplatelets (B01AC06, B02AC07, B01AC04, A01AD05, 
N02BA01), anticoagulants (B01AA03, B01AB, B01AE, B01AF), antihypertensives (C02, 
C03, C07, C08, C09) and statins (C10AA). 
Data Analysis 
The proportion of all problems that were a ‘new TIA’ was calculated with 95% Confidence 
Interval (95% CI).  
Associations of a registrar seeing a ‘new TIA’:  
Univariate and multivariable analyses were conducted with outcome factor ‘new TIA’ 
(compared to all other problems). 
Logistic regression was used within the generalised estimating equations (GEE) framework to 
account for repeated measures within registrars. An exchangeable correlation structure was 
assumed. 
Covariates with a p-value < 0.20 and a relevant effect size in the univariate analysis were 
included in the multivariable regression model. 
Covariates which had a small effect size and were no longer significant (at p < 0.05) in the 
multivariable model were removed from the final model as long as the covariate’s removal 
did not substantively change the resulting model. 
Management of TIA:   
The guidelines(8) recommend that a TIA be assessed with urgent imaging of the brain and the 
vessels supplying it, investigated with basic blood tests and an electrocardiogram, reviewed 
 by a stroke specialist (within 24 hours for high risk TIA and 7 days for low risk, as assessed 
by the ABCD2 score), and early initiation of secondary prevention consisting of antiplatelet 
therapy (or anticoagulant where required), initiation or intensification of anti-hypertensive 
therapy, and statin therapy. Low risk TIA should be managed in a specialist secondary care 
setting, but it is recognized that management may need to be in general practice if no 
specialist service is available. The guidelines specify that blood tests, brain and carotid 
imaging and ECG should be initiated at the first point of healthcare contact, whether first seen 
in primary or secondary care. Thus, for presentations of ‘new TIAs’ we calculated (with 95% 
CIs) the proportion of presentations for which ‘brain imaging’ (computed tomography or 
magnetic resonance imaging), ‘arterial imaging’ (ultrasound, magnetic resonance angiogram, 
cerebral angiogram), and ‘blood test’ (being any one of full blood count, electrolytes urea and 
creatinine, blood glucose, or fasting lipids being requested); the proportion of patients 
‘referred’ (to neurologist, general physician, emergency department, or hospital clinic); the 
proportion of patients for whom prescription was made for secondary prevention medications 
(being an antiplatelet or anticoagulant, antihypertensive and statin); and, as a proxy for 
guideline compliance, the proportion of presentations for which there was ‘action taken’ (the 
patient was either referred or all four of these actions occurred: brain imaging, arterial 
imaging, electrocardiogram and any one of an antiplatelet, anticoagulant, antihypertensive or 
statin prescribed). We adopted this approach because we do not have data for pre-existing 
medications. We expect that for the great majority of patients there will need to be at least one 
medication change made to comply with guideline recommendations for commencement or 
dose-intensification of secondary prevention medications.(5) We also assumed that referral 
was urgent and, though not entirely consistent with guidelines, would result in expedited 
investigation in secondary care. 
Analyses were programmed using Stata 13.1 (Statacorp, College Station, TX, USA) and SAS 
V9.4 (SAS Institute Inc., Cary, NC, USA). 
Ethics approval 
 The ReCEnT project has approval from the University of Newcastle Human Research Ethics 
Committee, Reference H-2009-0323. 
 
Results 
1,331 registrars contributed 3,259 rounds of data (response rate 95.8%). The characteristics of 
registrars and their practices are presented in Table 1: 65.5% of registrars were female, 80.6% 
were initially qualified in Australia, 83.8% worked in major cities or inner regional areas and 
65.9% worked in practices with 5 or more GPs. 
There were 250,625 problems (from 154,090 consultations) for patients aged 18 years or 
over, in the 14 rounds of data collection. Of these, 65 problems (0.03% [95% CI: 0.02%-
0.03%]) were new TIA problems in 0.04% [95% CI 0.03%-0.05%] of consultations.  TIA 
(new or old) was addressed in 0.07% [95%CI: 0.06%-0.09%] of consultations. 
Characteristics of new TIA problems are summarised in Table 2.  Results for the 
multivariable model are presented in Table 3. It shows GP-registrars were significantly more 
likely to seek in-consultation help or advice for a new TIA problem, generate learning goals 
and spend more time compared to other problems. GP-registrars working in an inner regional 
location were significantly more likely to see a new TIA than their colleagues working in 
major cities. Older patient age was also significantly associated with a new TIA problem.  
Management aspects of new TIA problems are presented in Table 4: brain and arterial 
imaging was ordered in 15.4%, 38.5% were referred for specialised care, 36.9% had an 
antiplatelet prescribed but only 40.0% satisfied our “action taken” variable .  
 
Discussion 
 The proportion of consultations entailing a new presentation of TIA to GP-registrars in our 
study is very low (0.04%), as is that for TIA new or old (0.07%). This compares to 0.2% for 
management of TIA by established GPs in an earlier Australian study,(21) which reported all 
consultations for TIA and did not report specifically on new presentations. In comparison, a  
UK neurology trainee recorded all diagnoses (5,246) encountered during training – of these 
2.1% were TIA and 1.1% were new TIAs.(22)  Whilst this is only a single trainee it highlights 
the gulf of experience between the GP and the expert. Our findings indicate that GP-registrars 
have little exposure to TIA diagnosis and management. This low exposure may therefore limit 
opportunity to learn and embed best-practice management to reduce the risk of recurrent 
stroke.(5)  
Our data demonstrates an association between a new presentation of TIA and increasing age 
which is consistent with the epidemiology of TIA.(7) That GP-registrars working at inner 
regional practices are more likely to see a new TIA than their major city counterparts is a 
finding with implications for health services delivery.   
The multivariable analysis indicates that managing a new TIA is not straightforward for GP-
registrars. The significant associations of a new TIA with longer consultations, increased 
likelihood of seeking help, and of generating learning goals strongly suggest that GP-
registrars find TIA a particularly challenging presentation, consistent with recent qualitative 
findings(11). GP-registrars are not alone in finding TIA challenging, as there is evidence that 
established GPs and emergency department physicians find diagnosis difficult.(11, 23) Even 
agreement between stroke-trained neurologists can be poor for TIA diagnosis.(24) However, 
having reached a diagnosis of TIA it is reasonable to expect adherence to management 
guidelines. 
There was limited adherence with guideline recommendations for all elements of TIA 
management with 15.4% ordering brain and arterial imaging, 36.9% prescribing protective 
antiplatelet medication, 3.1% prescribing antihypertensive medication, and 38.5% being 
 referred. Only 40.0% of new TIA problems meet our proxy measure for adequate guideline 
compliance. This suggests management of new TIA problems is far from ideal (even when 
assuming optimal rapid assessment and management of patients who were referred). There 
were low proportions of relevant imaging, investigations, and secondary prevention. Our 
findings are concerning because rapid early management of suspected TIA at first medical 
contact is an opportunity for effective prevention of recurrent stroke.(5) 
 
Limitations and Strengths 
Our study’s high response rate, unusual for studies in general practice,(25) is a strength. 
The proxy marker for guideline compliance, ‘action taken’, is an imprecise marker for 
appropriate management of TIA, as we cannot determine the urgency of referrals, whether 
patients attended appointments or complied with treatments and investigations.  Also, our 
ascertainment of prescribed pharmacotherapy is limited by our lack of information relating to 
the patient’s pre-existing medications. The EXPRESS study(5) of a TIA clinic in Oxford, UK, 
demonstrated that after a TIA, antiplatelet therapy was initiated in over 57% of patients, 
clopidogrel (usually in addition to aspirin) in over 50%, a statin in over 70%, a first 
antihypertensive medication in over 60% and almost 40% had a second antihypertensive 
commenced. Consequently, initiation of new medicines or intensification of existing 
medications would be expected actions in the great majority of new TIAs and our 
methodology would capture this. In defining ‘action taken’ we required only one of the 
secondary prevention medications to be initiated or intensified during the consultation. 
Guidelines require three classes of medication to be addressed (antiplatelet or anticoagulant, 
antihypertensive and statin). We also assumed referral to be urgent and to result in expedited 
investigation. Consequently, our measure would tend to overestimate the compliance with 
guidelines which makes our finding of less than ideal compliance robust. 
 The study relies upon the GP-registrar identifying the problem as a TIA, and so our estimate 
of prevalence of new TIA presentations is subject to a risk of both under-reporting and over-
reporting. But our findings of registrars’ compliance with recommended investigation, 
management and referral are robust given that these are contingent upon the registrar’s 
diagnosis at the time of the consultation and that we have consultation-level documentation of 
the actual clinical behaviour and management choices of the GP-registrars. 
 
Implications for practice and further research 
The challenging nature of TIAs for GPs and GP-registrars is not likely to be just because of 
the inherent complexity of the problem but also because it is a relatively rare general practice 
presentation (meaning there is little opportunity to reinforce guideline management 
processes). However, the majority of TIAs do present in general practice(9) and therefore 
designing a model of care for TIA that enhances the ability of GPs to comply with the 
guidelines would have the greatest impact upon achieving best practice management of TIA. 
Increased access to acute TIA clinics would meet this challenge(26), but would be very 
resource intensive and logistically problematic in many areas, especially in areas outside 
major cities (including inner regional areas where our data suggests GPs are more likely to be 
consulted for TIAs).  In the absence of urgent access to face-to-face specialist care for many 
GPs and their patients with TIA, access to real-time specialist advice may be an alternative. A 
rapid access TIA telemedicine clinic could meet this need and be a major part in transforming 
care for TIA, as has been achieved with acute stroke care.(27) Rather than suffer diagnostic 
uncertainty and the risk it represents to compliance with secondary prevention while waiting 
for specialist review, a telemedicine clinic could offer early confirmation of diagnosis, 
regardless of geographic location of the patient, plus appropriate and timely follow-up to 
ensure secondary prevention is firmly established when needed(11). Future research could 
 assess the utility of a telemedicine TIA service. For GP-registrars our findings also suggest 
that education regarding early management of TIA is important. 
Conclusion 
TIA is a challenging problem for both early career GPs and established GPs. However, most 
patients with a TIA first present to general practice and therefore it is vital that appropriate 
management is commenced as early as possible in this setting. Given the relatively rare 
frequency of TIA presentations to an individual GP, an enhanced model of care that provides 
rapid access to expert TIA support and follow-up in general practice could help achieve best 
practice management.  
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Table 1: Demographics of participating registrars and their practices 
Variable Class n (%) [95% CI] 
        
     Registrar variables (n=1,331) 
Registrar Gender Male 459 (34.5) [32.0-37.1] 
 Female 872 (65.5) [62.9-68.0] 
Qualified as a doctor in 
Australia 
No 256 (19.4) [17.3-21.6] 
 Yes 1,064 (80.6) [78.4-82.7] 
      
     Registrar-term or practice-term variables (n=3,259) 
Registrar Training Term  Term 1 1,226 (37.6) [36.0-39.3] 
 Term 2 1,138 (34.9) [33.3-36.6] 
 Term 3 819 (25.1) [23.7-26.6] 
 Term 4 76 (2.3) [1.9-2.9] 
Registrar age (years) Mean (SD) 32.7 (6.4) 
Registrar worked at the practice 
previously 
No 2,320 (72.3) [70.7-73.8] 
 Yes 890 (27.7) [26.2-29.3] 
Registrar works fulltime No 715 (22.5) [21.1-24.0] 
 Yes 2,463 (77.5) [76.0-78.9] 
Does the practice routinely bulk 
bill 
No 2,635 (82.2) [80.8-83.5] 
 Yes 571 (17.8) [16.5-19.2] 
Number of GPs working at the 
practice 
1-4 1,082 (34.1) [32.5-35.8] 
 5+ 2,087 (65.9) [64.2-67.5] 
Rurality of practice Major City 1,863 (57.2) [55.5-58.9] 
 Inner Regional 867 (26.6) [25.1-28.2] 
 Outer regional or remote 526 (16.2) [14.9-17.5] 
SEIFA Index (decile) of 
practice 
Mean (SD) 5.6 (2.9) 
CI=Confidence Interval; SD=Standard Deviation 
 
  
Table 2: Characteristics associated with consultations involving a new TIA 
 New TIA 
Variable Class No Yes P 
Patient gender Male 85979 (35%) 30 (49%) 0.03 
 Female 157785 (65%) 31 (51%)  
Registrar gender Male 83591 (33%) 26 (40%) 0.30 
 Female 166969 (67%) 39 (60%)  
Term Term 1 96465 (38%) 24 (37%) 0.08 
 Term 2 85655 (34%) 28 (43%)  
 Term 3 62741 (25%) 9 (14%)  
 Term 4 5699 (2%) 4 (6%)  
Qualified as doctor in Australia No 47130 (19%) 15 (23%) 0.44 
 Yes 201465 (81%) 50 (77%)  
Practice size Small 86190 (35%) 24 (37%) 0.80 
 Large 157484 (65%) 41 (63%)  
Practice routinely bulk bills No 202549 (82%) 55 (85%) 0.61 
 Yes 44430 (18%) 10 (15%)  
Rurality of practice Major city 142100 (57%) 29 (45%) 0.005 
 Inner regional 66963 (27%) 30 (46%)  
 Outer regional or remote 41329 (17%) 6 (9%)  
Sought help any source No 213669 (85%) 36 (55%) <0.001 
 Yes 36891 (15%) 29 (45%)  
Learning goals generated No 199535 (83%) 29 (47%) <0.001 
 Yes 39882 (17%) 33 (53%)  
Patient age mean (SD) 49 (19) 65 (14) <0.001 
SEIFA index mean (SD) 5 (3) 6 (3) 0.10 
Consultation duration mean (SD) 19 (10) 31 (13) <0.001 
 
  
Table 3: Univariate and adjusted models for consultations involving a new TIA 
 Univariate Adjusted 
Variable Class OR (95% CI) p OR (95% CI) P 
Patient gender Female 0.57 (0.34, 0.93) 0.03 0.72 (0.42, 1.21) 0.20 
Term Term 2 1.32 (0.75, 2.30) 0.34 1.34 (0.72, 2.51) 0.35 
 Term 3 0.57 (0.26, 1.24) 0.16 0.82 (0.35, 1.90) 0.64 
 Term 4 2.65 (0.85, 8.22) 0.09 3.41 (0.97, 12.0) 0.06 
Rurality of practice Inner regional 2.19 (1.27, 3.76) 0.005 2.71 (1.44, 5.10) 0.002 
 Outer regional or remote 0.72 (0.30, 1.72) 0.46 0.94 (0.33, 2.65) 0.90 
Sought help any source Yes 4.72 (2.85, 7.82) <0.001 2.38 (1.24, 4.57) 0.01 
Learning goals generated Yes 5.87 (3.60, 9.56) <0.001 2.90 (1.58, 5.33) <0.001 
Patient age Per year increase 1.04 (1.03, 1.05) <0.001 1.04 (1.03, 1.05) <0.001 
SEIFA index Per decile increase 1.07 (0.99, 1.15) 0.10 1.09 (0.98, 1.21) 0.12 
Consultation duration Per minute increase 1.06 (1.05, 1.07) <0.001 1.05 (1.04, 1.06) <0.001 
 
 
  
Table 4: Management of problems diagnosed as a new TIA 
Action Proportion of new TIAs (95% CI) 
Brain imaging 27.7% (18.0%-40.1%) 
Arterial imaging 24.6% (15.5%-36.8%) 
Brain and arterial imaging 15.4% (7.3%-26.6%) 
Blood test (any one of full blood count, renal 
function, blood glucose, fasting lipids) 
16.9% (9.5%-28.4%)  
Electrocardiogram ordered 7.7% (3.2%-17.5%) 
Referred 38.5% (27.2%-51.1%) 
Antiplatelet prescribed 36.9% (25.9%-49.5%) 
Antihypertensive prescribed 3.1% (0.7%-11.9%) 
Statin prescribed 4.6% (1.5%-13.7%) 
Anticoagulant prescribed 0.0% 
Action taken (patient either referred or all of 
brain imaging, arterial imaging, 
electrocardiogram and any one of 
antiplatelets, anticoagulants, 
antihypertensives or statins prescribed) 
40.0% (28.6%-52.6%) 
 
